相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diverse Evolutionary Histories for β-adrenoreceptor Genes in Humans
Rachele Cagliani et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Prothrombotic polymorphisms, mutations, and their association with pediatric non-cardioembolic stroke in Asian-Indian patients
Arijit Biswas et al.
ANNALS OF HEMATOLOGY (2009)
Thrombin-activatable fibrinolysis inhibitor-a inhibitors: Drugs for sepsis or drugs for disseminated intravascular coagulation?
Carl-Erik Dempfle et al.
CRITICAL CARE MEDICINE (2009)
EF6265, a novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor, protects against sepsis-induced organ dysfunction in rats
Yuko Muto et al.
CRITICAL CARE MEDICINE (2009)
The Roles of Selected Arginine and Lysine Residues of TAFI (Pro-CPU) in Its Activation to TAFIa by the Thrombin-Thrombomodulin Complex
Chengliang Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulation
Pauline F. Marx et al.
BLOOD (2008)
Biochemical importance of glycosylation in thrombin activatable fibrinolysis inhibitor
Karlien Buelens et al.
CIRCULATION RESEARCH (2008)
Overdominance in the human genome and olfactory receptor activity
Santos Alonso et al.
MOLECULAR BIOLOGY AND EVOLUTION (2008)
Structure of activated thrombin-activatable fibrinolysis inhibitor, a molecular link between coagulation and fibrinolysis
Laura Sanglas et al.
MOLECULAR CELL (2008)
Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysis
Michael B. Boffa et al.
BLOOD (2008)
Comparative evaluation of stable TAFIa variants:: importance of α-helix 9 and β-sheet 11 for TAFIa (in)stability
E. Ceresa et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Curiouser and curiouser: Recent advances in measurement of thrombin-activatable fibirinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles
Michael B. Boffa et al.
CLINICAL BIOCHEMISTRY (2007)
Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis
Laurent O. Mosnier et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis
C. H. Martini et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Generation of a stable activated thrombin activable fibrinolysis inhibitor variant
Erik Ceresa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Spread of an inactive form of caspase-12 in humans is due to recent positive selection
YL Xue et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
DbRIP: A highly integrated database of retrotransposon insertion polymorphisms in humans
JX Wang et al.
HUMAN MUTATION (2006)
Measurement of procarboxypeptidase U (TAFI) in human plasma: A laboratory challenge
JL Willemse et al.
CLINICAL CHEMISTRY (2006)
Calibrating a coalescent simulation of human genome sequence variation
SF Schaffner et al.
GENOME RESEARCH (2005)
Natural selection on protein-coding genes in the human genome
CD Bustamante et al.
NATURE (2005)
Microcephalin, a gene regulating brain size, continues to evolve adaptively in humans
PD Evans et al.
SCIENCE (2005)
TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME Study
PE Morange et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation
M Stephens et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Haploview: analysis and visualization of LD and haplotype maps
JC Barrett et al.
BIOINFORMATICS (2005)
Generation and characterization of a highly stable form of activated thrombin-activable fibrinolysis inhibitor
PF Marx et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation
T Myles et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
libsequence: a C++ class library for evolutionary genetic analysis
K Thornton
BIOINFORMATICS (2003)
Impaired healing of cutaneous wounds and colonic anastomoses in mice lacking thrombin-activatable fibrinolysis inhibitor
EAT Velde et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Estimation of divergence times for major lineages of primate species
GV Glazko et al.
MOLECULAR BIOLOGY AND EVOLUTION (2003)
Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the North and South of Europe
I Juhan-Vague et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Two naturally occurring variants of TAFI (Thr-325 and Il-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.
M Schneider et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N
WD Campbell et al.
MICROBIOLOGY AND IMMUNOLOGY (2002)
Identification of polymorphisms in the promoter and the 3′ region of the TAFI gene:: evidence that plasma TAFI antigen levels are strongly genetically controlled
M Henry et al.
BLOOD (2001)
Pro-carboxypeptidase R is an acute phase protein in the mouse, whereas carboxypeptidase N is not
T Sato et al.
JOURNAL OF IMMUNOLOGY (2000)
Recent common ancestry of human Y chromosomes: Evidence from DNA sequence data
R Thomson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
mtDNA variation among Greenland Eskimos: The edge of the Beringian expansion
J Saillard et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
A novel carboxypeptidase B that processes native beta-amyloid precursor protein is present in human hippocampus
A Matsumoto et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
分享论文
